Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Fung

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
World Journal of Gastroenterology|September 26, 2022
Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogueAlnoor Ramji, Karen Doucette, Curtis Cooper, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2016
Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and CirrhosisRaoel Maan, Marjolein van Tilborg, Katja Deterding, et al.
Alimentary Pharmacology & Therapeutics|December 3, 2024
Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical TrialsEdo J Dongelmans, Jordan J Feld, André Boonstra, et al.
Alimentary Pharmacology & Therapeutics|August 12, 2025
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of TreatmentGrace Lai-Hung Wong, Edward Gane, Calvin Q Pan, et al.
The Journal of Clinical Investigation|April 15, 2025
Virus-associated inflammation imprints an inflammatory profile on monocyte-derived macrophages in the human liverJuan Diego Sanchez Vasquez, Shirin Nkongolo, Daniel Traum, et al.
Scientific Reports|July 21, 2019
Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patientsOndrej Podlaha, Edward Gane, Maurizia Brunetto, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 4, 2014
Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)Scott Fung, Stuart C Gordon, Zahary Krastev, et al.
Journal of Hepatology|November 7, 2017
Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis BHarry L A Janssen, Maurizia R Brunetto, Yoon Jun Kim, et al.
Journal of Hepatology|December 3, 2015
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patientsW Ray Kim, Thomas Berg, Tarik Asselah, et al.
Gut|November 6, 2025
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER)Edo J Dongelmans, Lesley A Patmore, Seng Gee Lim, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
World Journal of Gastroenterology|September 26, 2022
Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogueAlnoor Ramji, Karen Doucette, Curtis Cooper, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2016
Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and CirrhosisRaoel Maan, Marjolein van Tilborg, Katja Deterding, et al.
Alimentary Pharmacology & Therapeutics|December 3, 2024
Early HBcrAg and Anti-HBc Levels Identify Patients at High Risk for Severe Flares After Nucleos(t)ide Analogue Cessation-A Pooled Analysis of Two Clinical TrialsEdo J Dongelmans, Jordan J Feld, André Boonstra, et al.
Alimentary Pharmacology & Therapeutics|August 12, 2025
Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of TreatmentGrace Lai-Hung Wong, Edward Gane, Calvin Q Pan, et al.
The Journal of Clinical Investigation|April 15, 2025
Virus-associated inflammation imprints an inflammatory profile on monocyte-derived macrophages in the human liverJuan Diego Sanchez Vasquez, Shirin Nkongolo, Daniel Traum, et al.
Scientific Reports|July 21, 2019
Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patientsOndrej Podlaha, Edward Gane, Maurizia Brunetto, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 4, 2014
Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml)Scott Fung, Stuart C Gordon, Zahary Krastev, et al.
Journal of Hepatology|November 7, 2017
Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis BHarry L A Janssen, Maurizia R Brunetto, Yoon Jun Kim, et al.
Journal of Hepatology|December 3, 2015
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patientsW Ray Kim, Thomas Berg, Tarik Asselah, et al.
Gut|November 6, 2025
HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER)Edo J Dongelmans, Lesley A Patmore, Seng Gee Lim, et al.
Pageof 6